Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
企業コードDHR
会社名Danaher Corp
上場日Jan 16, 2106
最高経営責任者「CEO」Blair (Rainer M)
従業員数61000
証券種類Ordinary Share
決算期末Jan 16
本社所在地2200 Pennsylvania Ave NW Ste 800W
都市WASHINGTON
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号20037-1701
電話番号12028280850
ウェブサイトhttps://www.danaher.com/
企業コードDHR
上場日Jan 16, 2106
最高経営責任者「CEO」Blair (Rainer M)